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Abstract
Epidemiologists have used case-control studies to investigate enteric disease outbreaks for many 
decades. Increasingly, case-control studies are also used to investigate risk factors for sporadic 
(not outbreak-associated) disease. While the same basic approach is used, there are important 
differences between outbreak and sporadic disease settings that need to be considered in the 
design and implementation of the case-control study for sporadic disease. Through the 
International Collaboration on Enteric Disease “Burden of Illness” Studies (the International 
Collaboration), we reviewed 79 case-control studies of sporadic enteric infections caused by nine 
pathogens that were conducted in 22 countries and published from 1990 through to 2009. We 
highlight important methodological and study design issues (including case definition, control 
selection, and exposure assessment) and discuss how approaches to the study of sporadic enteric 
disease have changed over the last 20 years (e.g., making use of more sensitive case definitions, 
databases of controls, and computer-assisted interviewing). As our understanding of sporadic 
enteric infections grows, methods and topics for case-control studies are expected to continue to 
evolve; for example, advances in understanding of the role of immunity can be used to improve 
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control selection, the apparent protective effects of certain foods can be further explored, and case-
control studies can be used to provide population-based measures of the burden of disease.
Introduction
Enteric infections caused by a variety of bacteria, viruses, and parasites represent an 
important public health problem worldwide (WHO, 2007). For health and regulatory 
agencies to design effective interventions to reduce the burden of disease, an understanding 
of the risk factors for infection is needed. Identifying these risk factors is challenging. 
Enteric pathogens often have multiple routes of transmission, including consumption of 
contaminated food or water, contact with animals or infected persons, as well as fomites and 
the environment. In addition, pathogens transmitted through food may be transmitted via 
many different food vehicles. Additionally, because most cases are sporadic, that is, not 
associated with a recognized outbreak (defined as two or more epidemiologically linked 
cases), their sources are not always investigated as part of routine public health activities. 
However, even when sporadic infections are fully investigated, most often the source cannot 
be identified.
Case-control studies are an important epidemiologic approach for attributing enteric 
illnesses to specific risk factors or exposures, by comparing recent exposures in populations 
of people with the disease of interest to those in controls who do not have the disease 
(Breslow et al., 1996; Batz et al., 2005; Scallan and Angulo, 2007b; Pires et al., 2009). Case-
control studies are often used during enteric disease outbreak investigations, but have been 
increasingly used to identify risk factors for sporadic illness (Dwyer et al., 1994). While the 
same approach is used to investigate both outbreak and sporadic disease, there are important 
differences in these epidemiologic settings that need to be considered in the design of the 
case-control study for sporadic disease.
The aim of case-control studies of sporadic disease is to inform public health and regulatory 
action by identifying risk factors at a population level. Thus, they differ in scope from case-
control studies in an outbreak setting, where the goal is to prevent additional illnesses, 
through identifying the specific common contaminated food source or other exposure. 
Because sporadic cases do not necessarily share a single specific common contaminated 
source, the epidemiologic signal from any single source is diluted, making true risk 
differences more difficult to detect. Even if a food type—for example eggs, spinach, or beef
—is an important source of sporadic infections, most servings of that food type are not 
contaminated, so the odds of a patient having consumed that food type may be only 
modestly higher than those of a control. Case-control studies of sporadic disease often 
quantify the magnitude of an exposure risk through the estimation of population measures 
such as the population attributable fraction (PAF); the PAF is a measure of the fraction of 
total disease in the population under study that would not have occurred if the effect 
associated with the risk factor of interest were absent. Because the magnitude of risk is 
assessed across multiple exposures, biases in the design or conduct of the study, such as 
selection bias or recall bias, can greatly impact the interpretation of study findings.
Fullerton et al. Page 2













The International Collaboration on Enteric Disease “Burden of Illness” Studies (hereafter, 
the International Collaboration) was started in 2004 by the U.S. Centers for Disease Control 
and Prevention (CDC) and the World Health Organization (WHO) to foster communication 
among groups conducting burden of foodborne disease studies and to provide a forum for 
technical assistance on developing such studies (Flint et al., 2005). In 2005, a working group 
was established within the International Collaboration to explore the methods used to 
conduct case-control studies of sporadic enteric disease; the working group had 
representatives from nine countries (Australia, Canada, Denmark, England, France, 
Germany, Malta, the Netherlands, and the United States). The group reviewed sporadic 
case-control studies conducted in various countries from 1990 through to 2009 and 
discussed key methodological issues influencing their validity. We summarize the review 
and working group discussions here and highlight how methods have changed over time.
Literature Review and Data Extraction
Eligible studies began on or after January 1, 1990, were published in English on or before 
December 31, 2009, and were identified by searching PubMed and by hand-searching the 
reference lists of retrieved articles. For the PubMed search, we used the following search 
terms: “case-control foodborne NOT outbreak” and “case-control enteric NOT outbreak” in 
the Title/Abstract. The titles/abstracts of all identified studies were read to exclude those that 
were not relevant, typically because they did not use a case-control study design or were an 
outbreak investigation or animal or laboratory study. Reference lists of relevant articles were 
also searched to identify additional candidate studies. The full texts of relevant articles were 
read to determine if they met the study inclusion criteria. When multiple reports from one 
study were found, only the initial report was included.
A data abstraction form summarizing the study design, study population, method of 
exposure assessment, and analysis methods was completed for each article by one reviewer 
(K.E.F.) (see Supplementary Material; available online at www.liebertonline.com/fpd). The 
data abstraction form was informed by the STROBE (Strengthening the Reporting of 
Observational Studies in Epidemiology) Statement, published in 2007, which provides 
guidance on how to improve the reporting of observational studies (including case-control 
studies) to facilitate critical appraisal and interpretation of studies (Vandenbroucke et al., 
2007; von Elm et al., 2007).
Study Characteristics
The initial PubMed search identified 686 possibly eligible studies. We retrieved 106 articles 
for full assessment, of which 79 met the eligibility criteria (Fig. 1). Studies were conducted 
in 22 countries: the United States (22, 28%), the United Kingdom (12, 15%), and Australia 
(9, 12%) (Table 1). Most studies were started between 1996 and 2002 (55, 70%), coinciding 
with the launch of formal surveillance networks such as FoodNet (started 1996) and 
OzFoodNet (started 2001), which provided platforms within which to conduct these studies; 
most studies (59, 75%) were published from 2001 to 2009. The median study period 
(defined by the number of months of case ascertainment) was 12 months (range, 1–132 
months); two studies did not report study length. Nine pathogens were studied (Table 2). 
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Four of the case-control studies were nested within larger cohort studies (Ghosh et al., 1997; 
Rodrigues et al., 2001; de Wit et al., 2003; Do et al., 2007).
The number of case-patients was 11–2,381 (median, 132 patients); the number of controls 
was 22–7,618 (median, 228).* Among the 59 (75%) studies reporting a case-patient 
response rate, the median was 68% (range, 22–100%). Among the 24 (31%) studies 
reporting a control response rate the median was 69% (range, 22–92%). Less than a quarter 
of the studies reported power calculations and calculated sample size (16% of studies) 
(Table 3).
Population summary measures (primarily population attributable fractions derived from the 
odds ratios) were reported in just over half of the studies (51%) (Table 3); most studies 
reporting a population attributable fraction were conducted after 1996.
Key Methodological Issues
The International Collaboration working group identified three key methodological issues 
considered to have the greatest influence on the validity of case-control studies of sporadic 
enteric disease: (1) accurate identification of cases (case definition), (2) the selection of an 
appropriate control group (control selection), and (3) accurate definition and measurement 
of the exposures of interest (exposure assessment).
Case Definition
The case definition used in case-control studies can be considered from two perspectives: 
the conceptual definition of a case of illness (or case-patient with that illness), which defines 
which case-patients are eligible for the study through the application of inclusion and 
exclusion criteria, and the operational task of identifying a participating case-patient, where 
only a subset of eligible case-patients are enrolled on account of practical, or operational, 
considerations. Both aspects (conceptual and operational) need to be considered when 
designing a study. Exclusion criteria may include things such as where the case-patient lives 
(to ensure that cases arose from the target population), outbreak status (to ensure that cases 
are not associated with an outbreak or are not secondary cases), age of the case-patient, 
international travel history (if the focus is on domestically acquired cases), and the presence 
of symptoms (case-patients who are unable to recall when their symptoms began or who do 
not report symptoms are typically not eligible). Once eligible case-patients are identified, 
operational, or practical, considerations may govern which are actually enrolled. For 
example, case-patients may not be enrolled because they cannot be reached (i.e., there is no 
phone in the home, or they do not respond to multiple call attempts); if reached, case-
patients may not be enrolled because they refuse to participate or because they do not speak 
the language of the interviewer or questionnaire, or they may be otherwise unable to answer 
the questions.
*This review included a registry-based case-control study conducted in Denmark (Ethelberg et al., 2005), with > 22,000 case-patients 
and >318,000 controls; this study is not included in these numbers, because the conduct of the study did not include actual contact/
interview of all the cases and controls.
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Nearly all of the studies in this review (73 studies, 92%) used a laboratory-based definition 
of a case, requiring some level of microbiological confirmation or subtyping information; all 
of these studies identified cases through laboratory-based surveillance systems. Laboratory-
confirmed Salmonella (24 studies, 31%) infections, including infection with specific 
Salmonella serotypes (17 studies), and Campylobacter infections (23 studies, 29%) were the 
most common infections studied (Table 2). Six studies used a symptom-based definition for 
diarrhea or gastroenteritis and identified cases through hospitals, clinics, or general 
practitioners. Unlike an outbreak where additional cases are typically identified through 
active case finding, there was no additional case finding in these studies beyond those cases 
of infection identified through surveillance systems and hospital or clinic registries. These 
studies are therefore subject to a differential selection bias because case-patients generally 
represent more severe disease than that experienced by undiagnosed and unreported case-
patients (Sethi et al., 1999; Tam et al., 2003; Scallan et al., 2006). It is not known if the risk 
factors differ between reported and unreported case-patients.
Most studies (92%) reported the criteria used to exclude case-patients. It was common to 
exclude patients with secondary cases (individuals with illnesses that were associated with 
household clusters of illness and were not the first illness in the household); of the 42 studies 
that reported excluding some illnesses associated with household clusters, 37 (88%) 
included only the case-patient with the earliest onset of illness, sometimes referred to as the 
index case. It was also common to exclude cases associated with outbreaks. An alternative 
to excluding all outbreak-associated cases is to include only the first case in the outbreak and 
exclude subsequent cases, so that the exposures associated with illness in the outbreak are 
present in the final analysis. Of the 51 studies that explicitly excluded outbreak-associated 
cases, seven (14%) included the first case of the outbreak. International travel before illness 
was another common exclusion criterion, used in 25 studies (31%). Because international 
travel can itself be an important risk factor for enteric disease, the risk associated with travel 
can be examined by including patients reporting international travel before illness (Eberhart-
Phillips et al., 1997; Kassenborg et al., 2004b; Stafford et al., 2006). Specific age groups 
were studied in 11 studies (14%); four studies focused on infants (Tenkate and Stafford, 
2002; Rowe et al., 2004; Jones et al., 2006b; Fullerton et al., 2007).
Tracking excluded case-patients and controls, and the reason for their exclusion or loss 
allows for calculation of participation and response rates and determination of the adherence 
to predetermined criteria for participation (Fig. 2). While 92% of studies reported the criteria 
used to exclude case-patients, only 78% reported the criteria used to exclude controls; all of 
these studies used the same exclusion criteria as was used for case-patients. Over half of the 
studies reported the number of eligible case-patients excluded (54%), while less than 15% of 
studies reported the number of potential controls excluded. Flow diagrams were used to 
illustrate the study population in some of the studies (Varma et al., 2006, 2007; Jones et al., 
2006b; Voetsch et al., 2007; Denno 2009), and their value has been recognized in the 
reporting of randomized controlled trials (Egger et al., 2001).
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For study validity, it is important that selected controls would have had the same opportunity 
to be recognized as case-patients if they had been exposed and developed disease, thus they 
must come from the same source population and geographic area (i.e., catchment area) as 
the cases. The catchment area of the surveillance system from which the cases are identified 
should define the catchment area for the controls. In practice, this can be hard to assure, 
particularly where the laboratory-based surveillance systems or registries used to identify 
cases are not population-based (i.e., do not cover a defined catchment area.)
Controls are frequently selected from the general population. However, even when controls 
are selected from the same catchment area as case-patients, there is no guarantee that, had a 
control become ill, he or she would have sought medical care and been reported as were the 
case-patients. Controls may differ from case-patients who are ascertained in a laboratory-
based surveillance system by factors that affect the identification process that occurred for 
cases to be ascertained in the surveillance system. The selection of controls from persons 
with another laboratory-confirmed infection ensures that case-patients and controls are 
similar with regard to these factors affecting identification, though it may decrease the 
generalizability of the study findings to the general population (McCarthy and Giesecke, 
1999 and Giesecke; Wilson et al., 2008; Voetsch et al., 2009).
Almost half of the studies reviewed (36 studies, 46%) used population-based controls; the 
most common methods of identifying population-based controls were random or sequential 
digit dialing from telephone directories or registries (21 studies), and population registries 
(13 studies). Continued reliance on telephone-based methods of selection of controls is 
becoming increasingly problematic, as mobile telephones become more widely used. Most 
telephone directories or registries used to identify and recruit controls do not include mobile 
telephone numbers, and mobile telephone numbers are often not linked to the neighborhood 
or city in which the control lives.
The next most common source of controls was either a hospital or a clinic (17 studies, 22%). 
Other control sources included national- or state-based control banks (4 studies, 5%) or 
convenience samples (e.g., case nominated neighbors or friends; 5 studies, 6%). Ten studies 
(13%) used a combination of sources.
Matching
Matching was used in 69 studies (87%) in this review. Of these, 14 (20%) used frequency 
matching; the other 55 (80%) used individual matching. All of the studies that used matched 
designs reported the matching criteria used. Among the 43 studies that reported the number 
of matched controls per case, the average was two (range, 1–15 per case).
Matching of case-patients and controls is common and has historically been done to control 
confounding by the criteria on which matching is performed. It is primarily employed for 
study efficiency and practical considerations (Kleinbaum et al., 1982; Rothman et al., 2008). 
For example, matching can be used to ensure that controls come from the same source 
population as the cases; a common example is using sequential digit-dialing based on a case-
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patient’s phone number for geographical matching. The advantages and disadvantages of 
matching should be carefully considered before a matched design is selected, as matching 
may decrease the investigators’ ability to examine all exposures of interest. Matching can be 
done at either the individual or group level. When individual matching is employed and 
controls are questioned about the exposure window during which the case occurred, it is 
important to recruit and interview controls in a timely manner to reduce recall bias. With 
group, or frequency, matching, there is more operational flexibility, as the goal is to enroll 
controls so that the control group matches certain characteristics of the case-patient group. 
With individual matching, case-patients without matched controls are not included in the 
analysis, potentially reducing the power of the study; frequency matching allows all cases to 
be included in the analysis. If matching is employed, analyses appropriate to the matched 
design must be conducted (Kleinbaum et al., 1982; Hennekens et al., 1987; Rothman et al., 
2008).
Control misclassification
Case-control studies of sporadic enteric disease frequently include only controls who report 
no recent diarrheal illness (i.e., well or healthy controls). This practice is primarily 
motivated by a desire to avoid misclassification. The assumption is that controls reporting a 
recent diarrheal illness may actually have had mild undiagnosed cases of the illness under 
study, while controls with no recent history of diarrhea are less likely to have had an 
undiagnosed case of illness. In practice, however, rates of specific enteric infections are 
often quite low in a population; unless the infection being studied is hyper-endemic, it is 
unlikely that a control had diarrhea caused by the infection under study. In this review, 68% 
of studies that reported control exclusion criteria excluded controls with symptoms of 
illness.
The selection of controls from persons with another laboratory-confirmed infection can also 
minimize misclassification bias. Five studies in this review used controls with a laboratory-
confirmed infection other than the one under study: studies of Campylobacter (Gillespie et 
al., 2002 [used C. coli and C. jejuni cases as controls for C. jejuni and C. coli cases, 
respectively], and Wingstrand et al., 2006 [used non-campylobacteriosis bacterial 
gastroenteritis patients, mainly Salmonella spp., as controls]), Cryptosporidium (Pintar et al., 
2009 [used non-cryptosporidiosis laboratory-confirmed enteric disease cases as controls]), 
Listeria (Schlech et al., 2005 [used 1 case each of laboratory-confirmed Salmonella and 
Campylobacter as controls]), and Salmonella (Voetsch et al., 2009 [used other Salmonella 
serotypes as controls for Salmonella serotype Enteritidis cases]).
Misclassification of controls may also occur if there is protective immunity to the infection. 
Asymptomatic infections will remain undiagnosed, because medical care is not sought. 
Asymptomatically infected persons may be included in the control group, which could lead 
to underestimation of the risk of infection associated with vehicles of exposure. Recent 
studies in Denmark and the Netherlands on the burden of salmonellosis based on a national 
sero-survey have shown evidence that previous exposure is widespread (Mangen et al., 
2004; Simonsen et al., 2008). Despite this, none of the case-control studies under study 
incorporated any validation of susceptibility to infection among controls.
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Case-control studies rely on a person’s recall of a past exposure. Poor recall can result in a 
biased study with respect to exposure assessment; to minimize the differential effect of this 
bias, the use of standard questionnaires and trained interviewers can ensure that interviews 
are conducted as similarly as possible for each case-patient and control (Correa et al., 1994; 
Rothman et al., 2008). All the studies in this review used a standard questionnaire to assess 
exposures of case-patients and controls. Half of the studies administered questionnaires over 
the phone (39 studies, 49%); 14 studies (18%) used postal questionnaires (self-administered 
by the study participant), and nine studies (10%) conducted face-to-face interviews. Six 
studies used more than one method.
Because enteric diseases are commonly transmitted through food, most exposures assessed 
are related to the consumption of particular food items, and, in some instances, where and 
how that food item was prepared or consumed. The set of possible risk factors, or exposures, 
included in the questionnaire is determined by hypotheses derived from previous studies of 
the pathogen and outbreak investigations. The aim of case-control studies of sporadic enteric 
infection is to evaluate the general risk attributable to specific exposures at the population 
level, not for an outbreak, so the most meaningful questions may be relatively general (i.e., 
“consumption of any chicken,” as opposed to “consumption of Brand X chicken prepared at 
home”). However, more detailed exposure information can help to inform certain specific 
intervention efforts and regulatory actions, so investigators must decide the appropriate level 
of detail in assessing exposures based on the intended use of the results.
The time period about which study participants are asked to remember their exposures is 
referred to as the exposure window. The end of the exposure window is the point in time 
before the case-patient or control interview from when the case-patient or control is asked to 
recall their exposures. For case-patients, the end of the exposure window is usually illness 
onset, although, especially for infections with long incubation periods, not always; for 
controls, the end of the exposure window can vary. We define two exposure windows based 
on different endpoints: (1) the “case-patient onset-based window,” the timing of which is 
determined by the onset of the case-patient’s illness; this can apply to both case-patients and 
controls, and (2) the “control interview-based window,” which ends at the control interview 
and is an alternative exposure window for controls. Using the control interview-based 
window can be especially helpful to reduce recall bias in controls; this approach can be used 
even if case-patients and controls are matched. The length of the exposure window usually 
depends on the length and range of the incubation period of the infection being studied; the 
goal is to capture exposures that occurred just before the incubation period and, therefore, 
could have been the source of infection. It is important to consider the exposure window in 
the design phase of a case-control study; identical exposure windows will often, but not 
always, be used for both case-patients and controls.
In this review, most studies used the case-patient onset-based window (68 studies, 86%) for 
case-patients. Other points used as the end of the exposure window for case-patients 
included the case-patient interview (4 studies) and specimen collection date (3 studies), 
while four studies did not state the end of the exposure window. For controls, just over half 
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of the studies used the control interview-based window (42 studies, 54%), and 27 (39%) 
used the case-patient onset-based window.
The length of the exposure window for case-patients and controls varied depending on the 
pathogen being studied; the most common length was 7 days (24 studies, 31%), followed by 
5 days (13 studies, 17%). Only five studies (6%) did not report the length of the exposure 
windows for case-patients and controls. Three studies used multiple exposure windows of 
different lengths (i.e., 7 days, 3 days, and 1 day), all ending at case-patient illness onset, for 
assessing exposures to commonly consumed foods (Mølbak et al., 2002; Doorduyn et al., 
2005; Marcus et al., 2006). The use of this method was pioneered in a 2002 Danish study of 
sporadic Salmonella serotype Enteritidis infections, in which the magnitude of association 
between consuming eggs and infection increased with decreasing exposure windows,7 days 
to 3 days to 1 day (Mølbak et al., 2002).
Insights Gained from 20 Years of Investigations of Sporadic Infections
Approaches to the study of sporadic enteric disease have evolved and matured. Before the 
1990s, epidemiologic studies of enteric diseases focused largely on outbreak-associated 
disease. As information needs for policy-making increased, more data about the overall 
burden of and risk factors for enteric disease was needed. Consequently, more attention has 
focused on understanding sporadic disease, which comprises a large majority of enteric 
illnesses. Formal surveillance networks were established with the aim of demonstrating the 
burden of enteric diseases in the developed world, focusing on sporadic disease (Scallan and 
Angulo, 2007a,b; Kirk et al., 2008; PHAC, 2008; Majowicz et al., 2010). These surveillance 
networks facilitated landmark research studies into sporadic enteric disease (Wheeler et al., 
1999; Tam et al., 2003, de Wit 2001, Voetsch et al., 2004; Jones et al., 2006a). Many of 
these surveillance systems have provided population-based platforms for case-control 
studies.
Specific lessons learned in the past 20 years include the need for careful consideration of the 
size of the study and the need to pay close attention to the set of exposures being assessed. 
Case-control studies of enteric infections, particularly those conducted over multiple years, 
are complex and resource-intensive undertakings, potentially involving multiple surveillance 
systems, local and regional health authorities, multiple laboratories. These studies need an 
adequate budget and suitably qualified personnel to coordinate and organize. A study should 
obviously be large enough to have adequate power to show an effect in the desired analyses. 
Investigators accustomed to outbreak investigations, which often need only small samples to 
demonstrate the very strong association that typically exists for the outbreak vehicle, should 
keep in mind that many of the effects associated with sporadic disease may be weak, even 
though population attributable fractions may be large, particularly for common exposures. 
Additionally, if the contaminated sources of sporadic infections are very diverse, and only a 
small fraction of cases is caused by a certain exposure, there may be insufficient power to 
show an association, even if the effect is strong. In a recently completed case-control study 
of Campylobacter infection in England, for example, a sample size of 1,500 cases and 1,500 
controls was needed for 80% power to detect a minimum odds ratio of 1.39 at the 0.05 
significance level. The sample size was based on chicken consumption as the main exposure 
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of interest and assumed a prevalence of 87% in the control population of eating any chicken 
in the 10 days before interview (Tam et al., 2009). This example illustrates the general fact 
that, when exposure frequency in the control population is very high, large studies are 
needed to demonstrate effects, a situation analogous to that found in many epidemiologic 
studies of chronic disease.
The selection of exposures about which cases and controls are queried is a key component of 
the design of these studies, in turn relying on the articulation of clear research questions with 
plausible hypotheses before the study. A successful case-control study is one that accurately 
and precisely identifies valid risk factors for infection or disease that can be used to guide 
practical interventions to prevent illness. Case-control studies of enteric disease are 
conducted for many reasons, including the following three: (1) as exploratory research into 
potential risk factors, (2) to confirm existing hypotheses, or (3) to inform policy. Usually, a 
study will aim to address all three. The plausible hypotheses should take into account 
country-specific information such as food consumption patterns and food distribution. Case-
control studies can identify novel risk factors for enteric disease; follow-up research can 
confirm, refute, or further explore these exposures, as their association with illness may not 
be causal. Some recently identified novel risk factors, for some of which further research has 
been conducted, include contact with sandboxes, associated with Salmonella serotype 
Typhimurium infections in the Netherlands (Doorduyn et al., 2005), consuming hummus or 
melons prepared in commercial establishments, associated with Listeria infections in the 
United States (Varma et al., 2006), and, for infants, riding in shopping carts next to meat or 
poultry, associated with Salmonella and Campylobacter infections in the United States 
(Jones et al., 2006b; Fullerton et al., 2007).
Many areas for further research exist to improve the validity and usefulness of case-control 
studies of enteric disease. Some prominent examples include the interpretation of 
“protective factors” and the role of immunity. One consistent finding across many case-
control studies of enteric infections, regardless of pathogen, is the identification of factors 
negatively associated with infection, or so-called “protective factors.” While some 
exposures are expected to be protective against enteric infections (e.g., breast feeding in 
infants, drinking filtered water), the interpretation of findings that suggest that the 
consumption of certain foods is associated with decreased risk is not straightforward. 
Several explanations in addition to causal effect (i.e., that the identified factor does indeed 
confer protection from infection when consumed) have been offered, including bias due to 
differential recall of exposure between case-patients and controls or due to confounding. 
Confounding could be at play if protective factors are associated with other unmeasured 
factors that affect risk, such as lifestyle factors or socioeconomic factors. As further 
discussed below, it is also possible for “protective” associations to be observed with 
exposures that are actually risky but that occur frequently and lead to protective immunity 
(Kapperud et al., 1998, 2003; Swift and Hunter, 2004; Stafford et al., 2006; Voetsch et al., 
2007).
The impact of individual immunity on the comparison of case-patients and controls, 
particularly for Campylobacter infections, is intriguing and warrants further exploration 
(Adak et al., 1995; Friedman et al., 2004; Havelaar et al., 2009). While the impact of the 
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immune status of controls on the results of case-control studies is unknown, and to the 
extent that exposure to common sources of infection may be associated with protective 
immunity, it can be presumed that if controls are immune to the particular infection under 
study then the measures of association between risk factors and infections may be decreased; 
true risk factors may appear to be less strongly associated with illness or may even appear to 
be protective factors. It has been suggested that protective factors may be found where there 
is longstanding or lifelong protective immunity owing to exposure to the pathogen over 
many years; however, this may not be the case for some enteric infections (Swift and 
Hunter, 2004; Havelaar et al., 2009). A history of previous exposure to the pathogen in an 
individual (leading to individual immunity) could be a confounder of the association of 
current exposure and infection and could be treated as such through the study design and 
analysis (Rothman and Mahon, 2004). Consequently, case-control studies of sporadic 
infections that are unable to include information on the immune status of participants may 
be better able to identify risk factors where exposure is only occasional, where the pathogen 
is uncommon, where protective immunity is not long-lasting. Alternatively, collecting 
information about chronic as well acute exposures could allow for control for confounding 
by previous immunity in analysis. An important advance in methodology for case-control 
studies would be the ability to use rapid antibody tests to determine the immune status of 
controls, allowing inclusion of only non-immune controls.
Attribution of foodborne illness to specific food commodities (Adak et al., 2005; Painter et 
al., 2009; Pires et al., 2009) has become a high priority for regulatory authorities in many 
countries. Thus, using consistent methods to define foods and food commodities across 
countries is becoming increasingly valuable. Additionally, a potential next step in the 
evolution of the analysis of case-control studies of sporadic enteric disease is to estimate the 
total number of illnesses caused by a specific exposure. One approach is to combine 
population attributable fraction proportions with surveillance data and reporting multipliers; 
in Australia, this type of analysis estimated that 50,500 Campylobacter infections annually 
occurred because of consumption of contaminated chicken (Stafford et al., 2008).
Conclusion
Previous reviews of case-control studies have considered methods and included studies from 
a broad range of disease areas (Wingo et al., 1998; Pocock et al., 2004; Knol et al., 2008). 
We review methods used in case-control studies of sporadic enteric infections.
The case-control design is useful for describing the relative importance of a range of risk 
factors for sporadic enteric infections, and can identify possible risk factors. As our 
understanding of sporadic enteric infections grows, methods, topics, and uses for case-
control studies are expected to continue to evolve; for example, advances in understanding 
of the role of immunity can be used to improve control selection, the apparent protective 
effects of certain foods can be further explored, and the studies can provide population-
based measures of the burden of disease.
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Flow chart of literature search for case-control studies of sporadic enteric infections.
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Example of flowchart that can be used to track cases enrolled in a case-control study of 
sporadic enteric disease, using a case-control study of Salmonella serotype Enteritidis as an 
example.
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Table 1
Case-Control Studies of Sporadic Enteric Infection Included in This Review, Conducted, and Published from 




USA 22 (28) Mead 1997, Slutsker 1998,
Kohl 2002, Khalakdina 2003,
Potter 2003, Friedman 2004,
Glynn 2004, Hennessy 2004,
Kassenborg 2004a
Kassenborg 2004b, Kimura 2004,
Mermin 2004, Rowe 2004,
Roy 2004, Jones 2006b
Marcus 2006, Varma 2006,
Aragon 2007, Fullerton 2007,
Voetsch 2007, Denno 2009
UK 12 (15) Gray 1994, Adak 1995, Hayes 1999,
Willocks 1996, Neal 1997,
Locking 2001, O’Brien 2001,
Rodrigues 2001,
Gillespie 2002, Parry 2002,
Stuart 2003, Tam 2009
Australia 9 (12) Tenkate 2001, Robertson 2002,
Cameron 2004, Beard 2004,
Hundy 2004, Ashbolt 2006,
Stafford 2006, Unicomb 2008,
McPherson 2009
Canada 5 (6) Le Saux 1993, Doré 2004, Currie 2005,
Schlech III 2005, Pintar 2009
France 5 (6) Delarocque-Astagneau 1998,
Yazdanpanah 2000,
Delarocque-Astagneau 2000,
Gallay 2008, Valliant 2009
Denmark 4 (5) Molbak 2002, Neimann 2003,
Ethelberg 2005, Wingstrand 2006
New Zealand 4 (5) Ikram 1994, Eberhart-Phillips 1997,
Satterthwaite 1999,
Baker 2006
Sweden 3 (4) Studhal 2000, Carrique-Mas 2005,
Boqvist 2009
Netherlands 2 (3) De Wit 2003, Doorduyn 2005
Norway 2 (3) Kapperud 1998, Kapperud 2003
Belgium 1 (1) Pierard 1999
Brazil 1 (1) Ferrer 2008
Finland 1 (1) Schonberg-Norio 2004
Germany 1 (1) Werber 2006
Italy 1 (1) Faustini 2006
India 1 (1) Ghosh 1997
Nepal 1 (1) Hoge 1996
Switzerland 1 (1) Schmid 1996
Trinidad
and Tobago
1 (1) Indar-Harrinauth 2001
Vietnam 1 (1) Trang 2007
Kenya 1 (1) Brooks 2003
Total 79
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Table 2
Case-Control Studies of Sporadic Enteric Infection Included in This Review, Conducted, and Published from 




Campylobacter 23 (29) Adak 1995; Gillespie 2002,
Cameron 2004; Carrique-Mas 2005;
Eberhart-Phillips 1997;
Ethelberg 2005; Friedman 2004;
Fullerton 2007; Gallay 2008;
Ikram 1994; Kapperud 2003;
Kassenborg 2004b; Neal 1997;
Neimann 2003; Potter 2003;
Rodrigues 2001;
Schonberg-Norio 2004;
Stafford 2006; Studhal 2000;
Tam 2009; Tenkate 2001;





7 Jones 2006b; Kapperud 2003;
Kohl 2002; Mermin 2004;




17 Ashbolt 2006; Baker 2006;
Beard 2004; Currie 2005;
Delarocque-Astagneau 1998;
Delarocque-Astagneau 2000;
Doorduyn 2005; Doré 2004;
Glynn 2004; Hayes 1999;
Hennessy 2004; Indar-Harrinauth 2001;
Kimura 2003; Marcus 2006; Molbak 2002;





8 (10) Kassenborg 2004a; Le Saux 1993; Locking 2001; Mead;






4 (5) Hundy 2004; McPherson 2009;
Pierard 1999; Valliant 2009;
Werber 2006
Cryptosporidium 4 (5) Khalakdina 2003; Pintar 2009;
Robertson 2002; Roy 2004
Giardia 3 (4) Faustini 2006; Gray 1994; Stuart 2003
Listeria 2 (3) Schlech III 2005; Varma 2007
Yersinia 2 (3) Boqvist 2009; Satterthwaite 1999




6 (8) Brooks 2003; Ferrer 2008;
Ghosh, 1997; Hoge 1996;
Trang 2007; Yazdanpanah 2000
Gastroenteritis
(viral)





1 (1) Denno 2009
Total 79
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Table 3
Frequency of Report of Specific Study Design and Analysis Characteristics by Studies Included in Review (n 
= 79)
Characteristic # studies (%)
Study Design Characteristics
Reported case-patient exclusion criteria 72 (91)
Reported number of case-patients excluded 42 (53)
Reported control exclusion criteria 61 (77)
Reported number of controls excluded 10 (13)
Reported case-patient response rate 59 (75)
Reported control response rate 24 (31)




Reported analytic methods used 79 (100)
Reported univariate results 79 (100)
Reported multivariate results 72 (91)
Reported population measure (i.e., PAF) 40 (51)
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